Paragon granted the Company a royalty-bearing, worldwide, exclusive and sublicensable license to use, make, sell, import, export and otherwise exploit certain antibodies and products targeting BAFF-R…
Under the Cell Line License Agreement, the Company received a non-exclusive, worldwide, sublicensable license to certain of WuXi Biologics Ireland's patent rights, know-how, cell line, biological mat…
Jade Biosciences, Inc. Customers
No clients on recordNo downstream customers found in our database for Jade Biosciences, Inc..
Jade Biosciences, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
JBIO-DEBT
Debt stack $849,000
90%
Market cache reports total debt of $849,000.
JBIO-DEBT-14390
Warrants outstanding: 11143000
90%
xbrl warrant detail from xbrl 2025-12-31.
JBIO-DEBT-10422
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2025-12-31.
Jade Biosciences, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Jade Biosciences, Inc..
Jade Biosciences, Inc. Ownership
Holder
Name
Confidence
Evidence
JBIO-OWNER-FMR-LLC
FMR LLC
90%
13F overlay lists FMR LLC as top holder; 122 tracked holders.
Jade Biosciences, Inc. Extended Supply Chain Network